KPI Therapeutics develops and commercializes clinical drugs for the treatment of autoimmune diseases... Read more
KPI Therapeutics develops and commercializes clinical drugs for the treatment of autoimmune diseases... Read more
News
Nov 29, 2017
BioPortfolio
KPI Therapeutics: KPI Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 08112017 Prices from USD $250
May 06, 2017
BioPortfolio
KPI Therapeutics: KPI Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 26042017 Prices from USD $250
Feb 28, 2017
BioPortfolio
KPI Therapeutics: KPI Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 17022017 Prices from USD $250
Jun 10, 2016
PR Newswire
Press Release: KPI Therapeutics : Alliance for Children's Therapeutics (ACT) Presents Dalazatide Data Demonstrating Positive Response in Lupus
Feb 22, 2016
The Business Journals
KPI Therapeutics: Seattle autoimmune biotech KPI plans clinical trials, looks to raise $25M
Feb 15, 2016
BioPortfolio
KPI Therapeutics: Video Interview KPI Therapeutics Chief Explains Company's Virtual Business Model
Feb 08, 2016
BioPortfolio
KPI Therapeutics: KPI Therapeutics Announces Expanded Drug Programs in Eye and Skin Diseases
Jun 05, 2014
BUSINESS WIRE
Press Release: KPI Therapeutics : Biotech Consortium Launches KPI Therapeutics, Inc., a New Collaborative Initiative to Speed Drug Development and Improve Investor Outcomes
Jun 04, 2014
CONTRACT PHARMA
KPI Therapeutics: Biotech Consortium Launches KPI Therapeutics
kpi therapeutics Competitors
1
2
3
4
5
6
7
8
9
10